InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.00
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,116.70
(
0.04%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5368
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: Rustler post# 4613

Tuesday, 01/17/2012 4:39:39 AM

Tuesday, January 17, 2012 4:39:39 AM

Post# of 26138
It appears that the partnership between Jazz and Azur could create some revenue for BPAX. As they focus on expanding the market for Elestrin.

According to the Jazz and Azur Partnership

• Significant growth opportunity driven by Elestrin , a topical gel ERT therapy
• Patents through 2022
• Revamped Elestrin promotion model in 2010 leveraging 51 sales representatives

If you look at page 12 of the slide presentation you will see that Elestrin is tracking in the right direction for future revenue growth.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up